July 28, 2021
RegMed Investors’ (RMi) pre-open: when and where are the bounces for the oversold?
July 27, 2021
RegMed Investors’ (RMi) pre-open: slippage, drippage or both
July 26, 2021
RegMed Investors’ (RMi) pre-open: last trading week of July and closer to sector Q2 earnings’ releases
July 23, 2021
RegMed Investors’ (RMi) pre-open: TGIF
July 22, 2021
RegMed Investors’ (RMi) pre-open: my internal Ouija board has lost its spirit
July 21, 2021
RegMed Investors’ (RMi) pre-open: algorithms could hack share pricing upsides
July 20, 2021
RegMed Investors’ (RMi) pre-open: recognition for the oversold or as good as it can get
July 19, 2021
RegMed Investors’ (RMi) pre-open: sector woes follow markets weakness
July 16, 2021
RegMed Investors’ (RMi) pre-open: wrapping a demoralizing share pricing week for the cell and gene therapy sector
July 15, 2021
RegMed Investors’ (RMi) pre-open: sector flounders with no news
July 14, 2021
RegMed Investors’ (RMi) pre-open: caution as jittery sentiment wraps markets yet our sector could feel an oversold jolt
July 13, 2021
RegMed Investors’ (RMi) pre-open: ricochet as sector struggles?
July 12, 2021
RegMed Investors’ (RMi) pre-open: Watching the rain come down
July 9, 2021
RegMed Investors’ (RMi) pre-open: Christmas in July or is there no gas for the grill?
July 8, 2021
RegMed Investors’ (RMi) pre-open: still staring into the abyss
July 7, 2021
RegMed Investors’ (RMi) pre-open: which way to the upside, it’s a crooked route
July 6, 2021
RegMed Investors’ (RMi) pre-open: fairly quiet, some bounces after Friday’s decline
July 2, 2021
RegMed Investors’ (RMi) pre-open: awaiting the jobs report and how many payrolls American employers added last month.
July 1, 2021
RegMed Investors’ (RMi) pre-open: what a difference news makes
June 30, 2021
RegMed Investors’ (RMi) pre-open: last trading day of 1st half, June and Q2
June 29, 2021
RegMed Investors’ (RMi) pre-open: reduce risk from new highs
June 28, 2021
RegMed Investors’ (RMi) pre-open: Q2 is coming to a close
June 24, 2021
RegMed Investors’ (RMi) pre-open: vulnerable to volatility post highs
June 23, 2021
RegMed Investors’ (RMi) pre-open: a cautious outlook
5 hours 41 min ago
RMi Pre-opening: Recoil, ricochet with a cold shiver
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.